Vol 82, No 6 (2024)
Original article
Published online: 2024-04-19

open access

Page views 236
Article views/downloads 136
Get Citation

Connect on Social Media

Connect on Social Media

Preliminary results from the Polish Infective Endocarditis Registry (POL-ENDO): Time to change clinical practice?

Jakub W Orzech1, Karina Zatorska1, Maciej Grabowski1, Małgorzata Miłkowska1, Maria Jaworska-Wilczyńska1, Ilona Kowalik2, Tomasz Kukulski3, Maciej Lesiak4, Andrzej Surdacki5, Tomasz Hryniewiecki1
Pubmed: 38644668
Pol Heart J 2024;82(6):609-616.

Abstract

Background: Infective endocarditis (IE) is a severe valvular disease associated with high morbidity and mortality.
Aims: This preliminary study aimed to evaluate patient profiles and treatment outcomes of IE in Poland and compare them with European IE characteristics.
Methods: We conducted a prospective multicenter observational cohort study — the POL-ENDO registry – in IE patients from 134 hospitals in Poland recruited between August 2022 and August 2023. We evaluated demographic, clinical, imaging, and treatment outcome data. A comparison of the Polish patients with those assessed in the EURO-ENDO registry between January 2016 and March 2018 was performed.
Results: Of a total of 880 IE patients, 622 were male (70.7%). The POL-ENDO participants were older (61.4 [16.7] years vs. 59.25 [18.03] years; P = 0.001). Native-valve IE occurred more often in Poland (82.3% vs. 56.6%; P <0.001). Transthoracic echocardiography was performed more frequently in Poland (93.6% vs. 89.8%; P <0.001). New imaging techniques (computed tomography/magnetic resonance imaging/positron emission tomography/single-photon emission computed tomography) were less frequently used in Poland (computed tomography: 41.3% vs. 53.2%; P <0.001; magnetic resonance imaging: 6.4% vs. 18.7%; P <0.001). Heart failure occurred more often in Poland as an in-hospital complication (31.4% vs. 14.1%; P <0.001). Surgical treatment was less frequently performed in Poland (36.9% vs. 51.2%; P <0.001). In-hospital mortality was higher in Poland (21% vs. 17%; P = 0.008).
Conclusion: Polish IE patients were significantly older and had more comorbidities. New imaging techniques are less frequently used in Poland. Echocardiography was performed more frequently in Poland as the diagnostic mainstay. Surgical treatment was significantly less frequent in Poland. In-hospital mortality in Poland is higher.

Article available in PDF format

View PDF Download PDF file

References

  1. Habib G, Erba PA, Iung B, et al. Clinical presentation, etiology, and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;; 40: 3222–3232.
  2. Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clin Med (Lond). 2020; 20(1): 31–35.
  3. Iung B. Infective endocarditis. Epidemiology, pathophysiology and histopathology [article in French[. Presse Med. 2019; 48(5): 513–521.
  4. Avtaar Singh SS, Costantino MF, D'Addeo G, et al. A narrative review of diagnosis of infective endocarditis-imaging methods and comparison. Ann Transl Med. 2020; 8(23): 1621.
  5. Ajam A, Shobeiri P, Keykhaei M, et al. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019. Int J Cardiol. 2022; 363: 202–209.
  6. Mutagaywa RK, Vroon JC, Fundikira L, et al. Infective endocarditis in developing countries: An update. Front Cardiovasc Med. 2022; 9: 1007118.
  7. Abramczuk E, Stępińska J, Hryniewiecki T. Twenty-year experience in the diagnosis and treatment of infective endocarditis. PLoS One. 2015; 10(7): e0134021.
  8. Płońska-Gościniak E, Olędzki S, Kukulski T, et al. Pol-CDRIE registry - 1-year observational data on patients hospitalized due to cardiac device-related infective endocarditis in Polish referential cardiology centres. Kardiol Pol. 2019; 77(5): 561–567.
  9. Dąbek J, Majewski M, Michalak-Kolarz M, et al. Patients with infective endocarditis: Five-year observation from a single reference center. Adv Clin Exp Med. 2017; 26(8): 1197–1205.
  10. Kong WKF, Salsano A, Giacobbe DR, et al. Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry [published correction appears in 2023; 44(21): 1909]. Eur Heart J. 2022; 43(29): 2770–2780.
  11. Jensen AD, Østergaard L, Petersen JK, et al. Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide study. BMC Cardiovasc Disord. 2022; 22(1): 338.
  12. Krčméry V, Hricak V, Fischer V, et al. Etiology, risk factors and outcome of 1003 cases of infective endocarditis from a 33-year national survey in the Slovak Republic: an increasing proportion of elderly patients. Neuro Endocrinol Lett. 2019; 39(8): 544–549.
  13. Castonguay MC, Burner KD, Edwards WD, et al. Surgical pathology of native valve endocarditis in 310 specimens from 287 patients (1985-2004). Cardiovasc Pathol. 2013; 22(1): 19–27.
  14. Alagna L, Park LP, Nicholson BP, et al. Repeat endocarditis: Analysis of risk factors based on the international collaboration on endocarditis - prospective cohort study. Clin Microbiol Infect. 2014; 20(6): 566–575.
  15. Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010; 11(2): 202–219.
  16. Koo HJ, Yang DH, Kang JW, et al. Demonstration of infective endocarditis by cardiac CT and transoesophageal echocardiography: comparison with intra-operative findings. Eur Heart J Cardiovasc Imaging. 2018; 19(2): 199–207.
  17. Hryniewiecki T, Zatorska K, Abramczuk E, et al. The usefulness of cardiac CT in the diagnosis of perivalvular complications in patients with infective endocarditis. Eur Radiol. 2019; 29(8): 4368–4376.
  18. Sitnik M, Cienszkowska K, Kobylecka M, et al. Insidious infective endocarditis: Should we use positron emission tomography more often? Pol Heart J. 2024; 82(2): 233–234.
  19. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023; 44(39): 3948–4042.
  20. Scholtens AM, Swart LE, Verberne HJ, et al. Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis. J Nucl Cardiol. 2018; 25(6): 1960–1967.
  21. Orvin K, Goldberg E, Bernstine H, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect. 2015; 21(1): 69–76.
  22. Liang F, Song B, Liu R, et al. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016; 22(3): 336–345.
  23. Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012; 366(26): 2466–2473.
  24. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023; 44(39): 3948–4042.



Polish Heart Journal (Kardiologia Polska)